This Week Health
Alex's Lemonade Stand This Week Health
<- Back to Insights
May 22, 2024

Thoma Bravo-Owned LogRhythm Announces Merger With Rival Exabeam

publication
|
Summary
LogRhythm, owned by private equity firm Thoma Bravo, has announced a merger with its SIEM market competitor Exabeam. Financial details were not disclosed, but Exabeam's latest valuation was $2.5 billion. The merger aims to leverage complementary strengths in AI-driven threat detection, investigation, and response, offering enhanced R&D, product innovation, and expanded support. Exabeam provides a SIEM platform known for its behavioral analytics and automated threat response capabilities. The deal is anticipated to close in Q3 2024, pending regulatory approvals.

Explore Related Topics

Subscribe Now to Receive Seven Top Stories Daily to Your Inbox

Subscribe News
Healthcare Transformation Powered by Community

© Copyright 2024 Health Lyrics All rights reserved